Skip to main content
Figure 2 | Microbial Cell Factories

Figure 2

From: Engineering the yeast Yarrowia lipolytica for the production of therapeutic proteins homogeneously glycosylated with Man8GlcNAc2 and Man5GlcNAc2

Figure 2

DSA-FACE analysis of mannoprotein N-glycans derived from different Yarrowia lipolytica strains. (A) Oligomaltose reference. (B-J) Different N-glycans. (B) Bovine RNaseB reference. (C) the MTLY60 wild type strain. (D) The same as panel C but treated with α-1,2-mannosidase. (E) The Δoch1 mutant strain. (F) The same as panel E but treated with α-1,2-mannosidase. (G) The Δmnn9 mutant strain. (H) The same as panel G but treated with α-1,2-mannosidase. (I) The Δoch1 Δmnn9 mutant strain. (J) The same as panel I but treated with α-1,2-mannosidase.

Back to article page

Microbial Cell Factories

ISSN: 1475-2859

Contact us